Daidzein inhibits carbohydrate digestive enzymes in vitro and alleviates postprandial hyperglycemia in diabetic mice.

doi:10.1016/j.ejphar.2013.04.047

Paper

Daidzein inhibits carbohydrate digestive enzymes in vitro and alleviates postprandial hyperglycemia in diabetic mice.

Published Jul 15, 2013 · Mi-hwa Park, J. Ju, Min Jung Park

European journal of pharmacology

Q1 SJR score

65

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Non-RCT

Animal Study

Rigorous Journal

Study Snapshot

Daidzein is a potent -glucosidase inhibitor and effectively suppresses postprandial hyperglycemia in streptozotocin-induced diabetic mice.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Daidzein inhibits carbohydrate digestive enzymes in vitro and alleviates postprandial hyperglycemia in diabetic mice.

Sign up to use Study Snapshot

References

Citations